Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011 | Value Researchhttps://www.valueresearchonline.com/stories/0b28819c-3e82-48b4-a05f-f0f7fd2b9be0/news-announcement/
Best Funds for 2023: Handpicked Mutual Funds to build a winning portfolio. (₹1,499 ₹999)
Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
29-Aug-2022
SHARE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 29 2022 for Ravi P Agrawal trustee Ravi Agrawal Trust